Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2011-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2011.03.067PMID 21550809PMCID PMC3138190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents.

  2009cited by this paper
• Web-Ice: Integrated Data Collection and Analysis for Macromolecular Crystallography

  2008cited by this paper
• Discovery of novel antitumor antimitotic agents that also reverse tumor resistance.

  2007cited by this paper
• Generating Conformer Ensembles Using a Multiobjective Genetic Algorithm

  2007cited by this paper
• Synthesis of 4-hydroxy-1-methylindole and benzo[b]thiophen-4-ol based unnatural flavonoids as new class of antimicrobial agents

  2005cited by this paper
• Phase I Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor in Patients with Refractory Solid Tumors

  2005cited by this paper
• Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.

  2005cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Thymidylate synthase inhibitors as anticancer agents: from bench to bedside

  2003cited by this paper
• Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines.

  2002cited by this paper
• An automated system to mount cryo-cooled protein crystals on a synchrotron beam line, using compact sample cassettes and a small-scale robot.

  2002cited by this paper
• 5-deazafolate analogues with a rotationally restricted glutamate or ornithine side chain: synthesis and binding interaction with folylpolyglutamate synthetase.

  1999cited by this paper
• Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.

  1999cited by this paper
• Antifolate Drugs in Cancer Therapy

  1999cited by this paper
• A concise synthetic entry to substituted 2-aminothieno[2,3-d]pyrimidines via a Gewald precursor

  1997cited by this paper
• Thymidylate synthase: structure, inhibition, and strained conformations during catalysis.

  1997cited by this paper
• The complex of the anti-cancer therapeutic, BW1843U89, with thymidylate synthase at 2.0 A resolution: implications for a new mode of inhibition.

  1996cited by this paper
• Promotion of purine nucleotide binding to thymidylate synthase by a potent folate analogue inhibitor, 1843U89.

  1995cited by this paper
• 5-Arylthio-substituted 2-amino-4-oxo-6-methylpyrrolo[2,3-d]pyrimidine antifolates as thymidylate synthase inhibitors and antitumor agents.

  1995cited by this paper
• Ligand-induced distortion of an active site in thymidylate synthase upon binding anticancerdrug 1843U89

  1995cited by this paper
• Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series.

  1995cited by this paper
• New Analogs of Methotrexate in Cancer and Arthritis

  1995cited by this paper
• The synthesis and thymidylate synthase inhibitory activity of L-gamma-L-linked dipeptide and L-gamma-amide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).

  1994cited by this paper
• Benzo[f]quinazoline inhibitors of thymidylate synthase: methyleneamino-linked aroylglutamate derivatives.

  1994cited by this paper
• Mode of binding of folate analogs to thymidylate synthase. Evidence for two asymmetric but interactive substrate binding sites.

  1994cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates.

  1993cited by this paper
• The measurement of polyglutamate metabolites of the thymidylate synthase inhibitor, ICI D1694, in mouse and human cultured cells.

  1993cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.

  1993cited by this paper
• A dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5- yl)ethyl]benzoyl]-L-glutamic acid, is an inhibitor of thymidylate synthase.

  1992cited by this paper
• The renewed potential for folate antagonists in contemporary cancer chemotherapy.

  1991cited by this paper
• The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).

  1991cited by this paper
• Quinazoline antifolate thymidylate synthase inhibitors: bridge modifications and conformationally restricted analogues in the C2-methyl series.

  1991cited by this paper
• Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines.

  1991cited by this paper
• ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

  1991cited by this paper
• Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 position.

  1990cited by this paper
• Expression of human thymidylate synthase in Escherichia coli.

  1989cited by this paper
• Folate analogues. 32. Synthesis and biological evaluation of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid and related compounds.

  1989cited by this paper
• Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitro.

  1988cited by this paper
• Folic acid metabolism and its disruption by pharmacologic agents.

  1987cited by this paper
• Functions of Tetrahydrofolate and the Role of Dihydrofolate Reductase in Cellular Metabolism

  1983cited by this paper
• Inhibition of Folate Metabolism in Chemotherapy

  1983cited by this paper
• Thymidylate synthetase - a target enzyme in cancer chemotherapy.

  1977cited by this paper
• Diastereoisomers of 5,10-methylene-5,6,7,8-tetrahydropteroyl-D-glutamic acid.

  1977cited by this paper
• 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 3. Synthesis of 5,6-disubstituted derivatives and related tetracyclic analogs.

  1973cited by this paper
• 2,4-Diaminopyrimidines from dicyandiamide. IV. Condensation with bicyclic aromatic ketones

  1972cited by this paper
• Heterocyclen aus CH‐aciden Nitrilen, VIII. 2‐Amino‐thiophene aus methylenaktiven Nitrilen, Carbonylverbindungen und Schwefel

  1966cited by this paper
• The enzymatic synthesis of thymidylate. I. Early steps in the purification of thymidylate synthetase of Escherichia coli.

  1962cited by this paper

• Synthesis and in vitro antitumor evaluation of new thieno[2,3-d]pyrimidine derivatives as EGFR and DHFR inhibitors.

  2024cites this paper
• Design and one-pot synthesis of new substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine as potential antitumor agents: in vitro and in vivo studies.

  2024cites this paper
• The Crystal Structure of 3-Amino-1-(4-Chlorophenyl)-9-Methoxy-1H-Benzo[f]Chromene-2-Carbonitrile: Antimicrobial Activity and Docking Studies

  2022cites this paper
• Identification of Active Compounds against Melanoma Growth by Virtual Screening for Non-Classical Human DHFR Inhibitors

  2022cites this paper
• Synthesis, Antitumor Activity, and In Silico Drug Design of New Thieno[2,3-d]Pyrimidine-4-One Derivatives as Nonclassical Lipophilic Dihydrofolate Reductase Inhibitors

  2022cites this paper
• The Complementarity Principle—One More Step towards Analytical Docking on the Example of Dihydrofolate Reductase Complexes

  2021cites this paper
• Electronic properties investigation of human dihydrofolate reductase complexes with ligands

  2020cites this paper
• Recent Design and Structure-Activity Relationship Studies on Modifications of DHFR Inhibitors as Anticancer Agents.

  2019cites this paper
• Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.

  2018cites this paper
• Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan

  2018cites this paper
• Synthesis and evaluation of new 2,6-diamino-5-hetarylpyrimidines as inhibitors of dihydrofolate reductase

  2018cites this paper
• Newest Developments in the Preparation of Thieno[2,3-d]pyrimidines

  2017cites this paper
• Investigation of Classical Organic and Ionic Liquid Cosolvents for Early-Stage Screening in Fragment-Based Inhibitor Design with Unrelated Bacterial and Human Dihydrofolate Reductases

  2017cites this paper
• Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities

  2017cites this paper
• The Gewald reaction in dye chemistry

  2016cites this paper
• Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication.

  2016cites this paper
• Oxidation of 4-nitro-o-xylene with nitric acid using N-hydroxyphthalimide under phase transfer conditions

  2015cites this paper
• The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents.

  2015cites this paper
• Oxidation of 4-nitro-o-xylene with nitric acid using N-hydroxyphthalimide under phase transfer conditions

  2015cites this paper
• Investigation of antimalarial drug pyrimethamine and its interaction with dsDNA by electrochemical and spectroscopic techniques

  2015cites this paper
• Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties.

  2015cites this paper
• Identification of Novel Potential Antibiotics against Staphylococcus Using Structure-Based Drug Screening Targeting Dihydrofolate Reductase

  2014cites this paper
• Application of Neural Network in Bioactive Prediction of Inhibitor of Thymidylic Acid-Based Synthetase

  2014cites this paper
• Effect of pyrimethamine treatment on male rat testicular cell population development

  2014cites this paper
• Synthesis and Molecular Modeling Studies of Bicyclic Inhibitors of Dihydrofolate Reductase, Receptor Tyrosine Kinases and Tubulin

  2013cites this paper
• An Innovative Strategy for Dual Inhibitor Design and Its Application in Dual Inhibition of Human Thymidylate Synthase and Dihydrofolate Reductase Enzymes

  2013cites this paper